top of page
pexels-adrien-olichon-3137037_edited.jpg

Pediatric Therapy M&A and Capital Markets UpdateActivity Remains Resilient Through April 2026

  • 4 days ago
  • 3 min read

Updated: 3 days ago

By Luis F. Lopez, PhD, President of Mergium Advisors


Executive Summary


Despite ongoing operational headwinds in pediatric therapy—including staffing constraints, reimbursement pressure, and broader macroeconomic uncertainty—transaction activity through April 2026 has remained resilient.


Mergium Advisors’ proprietary tracking indicates:

  • 11 M&A transactions completed in the first four months of 2026

  • 9 transactions in Q1 alone, consistent with the quarterly run-rate observed since 2022

  • Continued dominance of private equity-backed platform acquisitions 

  • Sustained investor interest in multi-disciplinary pediatric therapy models 


At the same time, capital continues to flow into technology-enabled providers, particularly those leveraging virtual care and differentiated delivery models.


M&A Activity Overview


Transaction Volume by Quarter

Period

Number of Transactions

Q1 2026

9

April 2026

2

Total (Jan–Apr 2026)

11

👉 Observation:Q1 deal volume is in line with historical quarterly averages since 2022, indicating that buyer demand remains intact despite market uncertainty.


Number of M&A Transactions in Pediatric Therapy per Quarter Q1 2020 to Q1 2026

Transactions by Buyer Type

Buyer Type

Number of Transactions

% of Total

PE-backed platform companies (add-ons)

7

64%

New private equity platform investments

2

18%

Strategic buyers (incl. non-profits)

2

18%

Total

11

100%


Key Trends in M&A Activity


1) PE-Backed Platforms Continue to Drive Consolidation

Private equity-backed platforms completed 7 add-on acquisitions, representing the majority of deal activity.

One notable transaction:

  • Ally Pediatric Therapy was sold by SBJ Capital to ACES. ACES is sponsored by General Atlantic.

Additionally:

  • Ally Pediatric Therapy had the largest footprint in the dataset (8 locations) 

👉 This confirms a critical trend:

Consolidation in pediatric therapy continues to be driven primarily by existing platforms—not new entrants.

These buyers remain focused on:

  • Geographic expansion

  • Clinician density

  • Service line expansion


2) Continued (Selective) Entry of New Private Equity Capital

Two transactions involved new private equity platform investments, signaling that:

Institutional capital continues to target scaled, multi-disciplinary pediatric therapy businesses.

However, entry remains selective, with emphasis on:

  • Strong compliance infrastructure

  • Diverse payor mix

  • Scalable clinical and operational models


3) Interest in Multi-Disciplinary Models

Service Mix

Number of Transactions

ABA-only

1

Multi-disciplinary (ABA/OT/PT/ST)

10

👉 Key takeaway:

Buyers looked for multi-disciplinary providers.

Drivers include:

  • Reduced reimbursement concentration risk

  • Cross-referral opportunities

  • Clinical integration

  • Improved scalability across markets

  • Alignment with evolving care models


4) Expansion of Care Delivery Models

Across transactions, targets included:

  • Clinic-based providers

  • In-home therapy models 

  • School-based service providers 

  • Community-based delivery platforms

👉 This reflects:

Growing buyer interest in flexible, multi-setting care delivery models aligned with family and payer preferences.


5) Integration of Behavioral Health Services

  • 2 transactions involved providers offering pediatric counseling alongside therapy services 

👉 This indicates:

Increasing convergence between pediatric therapy and mental health.


6) Strategic Buyers Remain Selectively Active

Two transactions involved strategic buyers:

Type of Strategic Buyer

Description

Non-profit organization

Autism + mental health + IDD services

School-based provider

ABA, OT, ST services

👉 Insight:

Strategic buyers remain active in mission-driven and education-integrated models.


Capital Raising Activity (Private Placements)

Announced Capital Raises

Company

Amount Raised

Focus

Model

Coral Care

$13M

Pediatric therapy (ST, OT, PT)

In-home, tech-enabled marketplace

AnswersNow

$40M

Autism therapy

Virtual BCBA-led model

Avela Health

~$7M

Autism diagnostics & support

Virtual care

Capital Markets Insight

The nature of these raises is telling:

  • Focus on technology-enabled delivery models 

  • Strong interest in virtual autism services 

  • Emphasis on parent-mediated and scalable care models 

👉 This signals:

Venture capital is increasingly targeting innovation layers on top of traditional pediatric therapy services.


What This Means for Owners and Investors


For Practice Owners

  • Buyer demand remains strong, particularly from PE-backed platforms

  • Buyers interested in multi-disciplinary providers 

  • Practices with:

    • Diverse payor mix

    • Strong compliance

    • Scalable operations

      are best positioned for premium outcomes


For Investors

  • Platform expansion is driving deal flow so far this year

  • Continued opportunity in:

    • Add-on acquisitions

    • Multi-service integration strategies


For the Market

Pediatric therapy is in the middle of a more mature consolidation phase, characterized by:

  • Strategic platform expansion

  • Selective new capital deployment

  • Continued innovation through venture-backed models


Final Takeaway

Despite industry-specific and macroeconomic challenges:

The pediatric therapy M&A market remains active, disciplined, and structurally healthy.

  • Consolidation is ongoing

  • Capital is still available

  • Buyers are more selective—but still highly engaged


 
 

LUIS F. LOPEZ, Ph.D.

President

(954) 806-4807
luislopez@mergium.com
contact@mergium.com

  • LinkedIn
  • X
  • Facebook

If you are interested in receiving information about the companies we sell, please fill out our questionnaire.

NEWSLETTER

Subscribe for our latest industry research & trends, resources for buyers & sellers, and more.

Thanks for subscribing.

Securities transactions conducted through StillPoint Capital, member FINRA/SiPC., Tampa, FL. Certain members of Mergium are Registered Representatives of the broker dealer StillPoint Capital, LLC. Mergium and StillPoint Capital LLC, are not affiliated entities. For more information on registered Representatives or Broker Dealers please visit FINRA Broker Check.

© 2026 Mergium Advisors 

Web design by Nick Lopez

bottom of page